Batoprotafib is a potent allosteric inhibitor of SHP2, with a reported IC50 of 0.011 µM, demonstrating strong selectivity. This orally active compound is essential for investigating receptor tyrosine kinase (RTK)-dependent malignancies, particularly in the context of advanced solid tumors. Batoprotafib serves as a valuable tool for research aimed at understanding the role of SHP2 in tumorigenesis and therapeutic responses.
Batoprotafib is a potent allosteric inhibitor of SHP2, with a reported IC50 of 0.011 µM, demonstrating strong selectivity. This orally active compound is essential for investigating receptor tyrosine kinase (RTK)-dependent malignancies, particularly in the context of advanced solid tumors. Batoprotafib serves as a valuable tool for research aimed at understanding the role of SHP2 in tumorigenesis and therapeutic responses.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
